You can now have your say about regulations on bringing stem cell therapies to the clinic. A special task force set up to create guidelines for bringing stem cell therapies from bench to bedside will be accepting public commentary on the guidelines, continuing until this fall, the group announced today at the annual meeting of the International Society for Stem Cell Research (ISSCR) here in Philadelphia. The task force's primary goals are to create guidelines that will help basic researchers address the regulatory challenges of stem cell therapies. In particular, the task force of more than 30 members from 13 countries will address issues of standardizing stem cell populations -- making sure each line is uncontaminated by others, and that the cells are at a uniform state of differentiation. Similar issues were discussed in April at a linkurl:meeting;http://www.the-scientist.com/blog/display/54544/ of the Food and Drug Administration. But it seems that the ISSCR...
Interested in reading more?
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?